# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-332940
Filing Date
2026-08-04
Accepted
2026-08-04 16:30:46
Documents
76
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | adpt-20260630.htm iXBRL | 10-Q | 3287750
2 | EX-31.1 | adpt-ex31_1.htm | EX-31.1 | 19243
3 | EX-31.2 | adpt-ex31_2.htm | EX-31.2 | 19237
4 | EX-32.1 | adpt-ex32_1.htm | EX-32.1 | 11947
5 | EX-32.2 | adpt-ex32_2.htm | EX-32.2 | 13340
| Complete submission text file | 0001193125-26-332940.txt |  | 12006971

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | adpt-20260630.xsd | EX-101.SCH | 1313331
79 | EXTRACTED XBRL INSTANCE DOCUMENT | adpt-20260630_htm.xml | XML | 2413258

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 261239303
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)